Salazar, J.; Pirela, D.; Nava, M.; Castro, A.; Angarita, L.; Parra, H.; Durán-Agüero, S.; Rojas-Gómez, D.M.; Galbán, N.; Añez, R.;
et al. Specialized Proresolving Lipid Mediators: A Potential Therapeutic Target for Atherosclerosis. Int. J. Mol. Sci. 2022, 23, 3133.
https://doi.org/10.3390/ijms23063133
AMA Style
Salazar J, Pirela D, Nava M, Castro A, Angarita L, Parra H, Durán-Agüero S, Rojas-Gómez DM, Galbán N, Añez R,
et al. Specialized Proresolving Lipid Mediators: A Potential Therapeutic Target for Atherosclerosis. International Journal of Molecular Sciences. 2022; 23(6):3133.
https://doi.org/10.3390/ijms23063133
Chicago/Turabian Style
Salazar, Juan, Daniela Pirela, Manuel Nava, Ana Castro, Lissé Angarita, Heliana Parra, Samuel Durán-Agüero, Diana Marcela Rojas-Gómez, Néstor Galbán, Roberto Añez,
and et al. 2022. "Specialized Proresolving Lipid Mediators: A Potential Therapeutic Target for Atherosclerosis" International Journal of Molecular Sciences 23, no. 6: 3133.
https://doi.org/10.3390/ijms23063133
APA Style
Salazar, J., Pirela, D., Nava, M., Castro, A., Angarita, L., Parra, H., Durán-Agüero, S., Rojas-Gómez, D. M., Galbán, N., Añez, R., ChacÃn, M., Diaz, A., Villasmil, N., De Sanctis, J. B., & Bermúdez, V.
(2022). Specialized Proresolving Lipid Mediators: A Potential Therapeutic Target for Atherosclerosis. International Journal of Molecular Sciences, 23(6), 3133.
https://doi.org/10.3390/ijms23063133